Mobile

Study of Aflibercept as Maintenance Following Induction of Aflibercept in Combination with XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient Studio con aflibercept come t...

Mise à jour : Il y a 4 ans
Référence : U1111-1143-3015

Study of Aflibercept as Maintenance Following Induction of Aflibercept in Combination with XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient Studio con aflibercept come terapia di mantenimento dopo induzione con aflibercept in combinazione con XELOX, come prima linea di trattamento in pazienti affetti da tumore del colon-retto metastatico

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Study Part 1: To determine the recommended dose for the aflibercept, oxaliplatin and capecitabine (XELOX) combination to be used in the Part 2 of the study Study Part 2: To assess the percentage of patients without progression of the disease at 6 months after the start of maintenance therapy with aflibercept single-agent, following the first-line induction therapy with XELOX and aflibercept combination in patients with previously untreated metastatic colorectal cancer

Critère d'inclusion

  • Colorectal cancer metastatic,tumore del colon retto, metastatico

Liens